Celltrion
Celltrion, established in 1991, is a South Korea-based biopharmaceutical company. The firm pioneered the launch of the world's first biosimilar monoclonal antibody and operates small molecule pharmaceuticals.
Celltrion
Celltrion, established in 1991, is a South Korea-based biopharmaceutical company. The firm pioneered the launch of the world's first biosimilar monoclonal antibody and operates small molecule pharmaceuticals. Celltrion distributes its products to over 90 countries globally.
General information
Firm type
Corporate Investor
Year founded
1991
AUM
—
Location
Region
—
Country
—
City
Incheon
Corporate office
23, Academy-ro Yeonsu-gu
Frequently asked questions
What is Celltrion?
Celltrion is a corporate investor headquartered in Incheon.
When was Celltrion founded?
Celltrion was founded in 1991.
Where is Celltrion headquartered?
Celltrion is headquartered in Incheon.
What does Altss track for Celltrion?
Altss maintains an OSINT-verified profile of Celltrion covering investment focus (ESG policy, ticket size, target IRR, currency preference, regional focuses, industry focuses, technological focuses), team (service providers and advisors), deals (company deals and fund commitments), assets (real estate, public market positions, private companies, art and cultural holdings, philanthropy and foundations), and network (club memberships, associations, and event participation). Detailed values are available to Altss subscribers.
What is Celltrion's website?
Celltrion's public website is www.celltrion.com. Verified contact details for principals and decision-makers are available to Altss subscribers.
What type of firm is Celltrion?
Celltrion is classified by Altss as a Corporate Investor.
How does Altss source intelligence on Celltrion?
Altss combines OSINT (open-source intelligence) with regulatory filings, public disclosures, and licensed data partners. Source provenance is tracked to support compliance-ready research workflows.
How fresh is the Altss profile for Celltrion?
Celltrion's profile is part of Altss's continuous-refresh dataset, with a full update cycle at least every 30 days and priority changes applied as new information is verified.
Company types
Confirmed
Pipeline
Indicated
Negative
Industry focuses
Confirmed
Pipeline
Indicated
Negative
Regional focuses
Confirmed
Pipeline
Indicated
Negative
Technological focuses
Confirmed
Pipeline
Indicated
Negative
Get access to Altss to unlock details
Get accessInvestment stages
Confirmed
Pipeline
Indicated
Negative
Emerging interests
Hard exclusions
ESG policy
Direct deal program
Emerging manager LP program
Get access to Altss to unlock details
Get accessManager maturity preference
Confirmed
Indicated
Ticket size (USD M, min/max)
Preferred fund size (USD M, min/max)
Investment horizon (years, min/max)
Target IRR (%)
Max leverage
Liquidity terms
Currency preference
Get access to Altss to unlock details
Get accessPhilanthropy-only themes
Political donations
Service Providers & Advisors
| Category | Firm | Years Active | Primary Contact |
|---|---|---|---|
Company Deals
| Date | Company | Type | Sector | Geography | Role | Amount | Deal Lead | Co-investors | Insight |
|---|---|---|---|---|---|---|---|---|---|
Get access to Altss to unlock details
Get accessFund Commitments
| Date | Fund | Strategy | Geography | Role | Fund size | Vintage |
|---|---|---|---|---|---|---|
Club Memberships and Associations & Advisors
| Organization | Role | Since | Notes |
|---|---|---|---|
Get access to Altss to unlock details
Get accessEvent & Conference Participation
| Event | Role | Date | Location |
|---|---|---|---|
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: